Octreotide stimulates somatostatin receptor-induced apoptosis of SW480 colon cancer cells by activation of glycogen synthase kinase-3β, a Wnt/β-catenin pathway modulator

Hepato-Gastroenterology

Volumn 60, Issue 127, 2013, Pages 1639-1646

  Wang, Song ^a   Bao, Zheng ^a   Liang, Qing Mo ^a   Long, Jian Wu ^a   Xiao, Zhong Sheng ^a   Jiang, Zhong Jun ^a   Liu, Bo ^a   Yang, Jie ^a   Long, Zhi Xiang ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Colon cancer; G protein coupled receptors; Glycogen synthase kinase 3 ; Octreotide; Somatostatin receptor; Wnt catenin

Indexed keywords

ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; BETA CATENIN; CELL LINE, TUMOR; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOGEN SYNTHASE KINASE 3; HUMANS; OCTREOTIDE; PHOSPHORYLATION; RECEPTORS, SOMATOSTATIN; RNA, MESSENGER; TCF TRANSCRIPTION FACTORS; TIME FACTORS; WNT SIGNALING PATHWAY;

EID: 84893912038     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11835     Document Type: Article

References (39)

1. King N, Hittinger CT, Carroll SB: Evolution of key cell signaling and adhesion protein families predates animal origins. Science 2003; 301(5631):361-363.
2. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov 2006; 5(12):993-996. (Pubitemid 44835126)
3. Fujino H, Regan JW: FP prostanoid receptor activation of a T-cell factor/beta-catenin signaling pathway. J Biol Chem 2001; 276(16):12489-12492.
4. Fujino H, West KA, Regan JW: Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. J Biol Chem 2002; 277(4):2614-2619.
5. Farías GG, Godoy JA, Hernández F, et al.: M1 muscarinic receptor activation protects neurons from beta-amyloid toxicity. A role for Wnt signaling pathway. Neurobiol Dis 2004; 17(2):337-348. (Pubitemid 39345789)
6. Yang M, Zhong WW, Srivastava N, et al.: G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the β-catenin pathway. Proc Natl Acad Sci U S A 2005; 102(17):6027-6032. (Pubitemid 40594249)
7. Yan W, Tai HH: Glycogen synthase kinase-3 phosphorylation, T-cell factor signaling activation, and cell morphology change following stimulation of thromboxane receptor alpha. J Pharmacol Exp Ther 2006; 317(1):267-274.
8. Gardner S, Maudsley S, Millar RP, et al.: Nuclear stabilization of beta-catenin and inactivation of glycogen synthase kinase-3beta by gonadotropin-releasing hormone: targeting Wnt signaling in the pituitary gonadotrope. Mol Endocrinol 2007; 21(12):3028-3038. (Pubitemid 350223512)
9. Roy L, McDonald CA, Jiang C, et al.: Convergence of 3′,5′- cyclic adenosine 5′-monophosphate/protein kinase A and glycogen synthase kinase-3beta/beta-catenin signaling in corpus luteum progesterone synthesis. Endocrinology 2009; 150(11):5036-5045.
10. Tejeda M, Gaál D, Hulián L, et al.: Evaluation of the antitumor efficacy of the somatostatin structural derivative TT-232 on different tumor models. Anticancer Res 2006; 26:3477-3483.
11. Wang CH, Tang CW, Liu CL, et al.: Inhibitory effect of octreotide on gastric cancer growth via MAPK pathway. World J Gastroenterol 2003; 9:1904-1908. (Pubitemid 37168410)
12. Liu HL, Huo L, Wang L: Octreotide inhibits proliferation and induces apoptosis of hepatocellular carcinoma cells. Acta Pharmacol Sin 2004; 25:1380-1386. (Pubitemid 39361813)
13. Reisine T, Bell GI: Molecular biology of somatostatin receptors. Endocrinol Rev 1995; 16:427-442.
14. Strowski MZ, Cashen DE, Birzin ET, et al.: Antidiabetic activity of a highly potent and selective nonpeptide somatostatin receptor subtype-2 agonist. Endocrinology 2006; 147(10):4664-4673. (Pubitemid 44402172)
15. Mitra SW, Mezey E, Hunyady B, et al.: Colocalization of somatostatin receptor sst5 and insulin in rat pancreatic beta-cell. Endocrinology 1999; 140(8):3790-3796. (Pubitemid 30645436)
16. Liebow C, Reilly C, Serrano M, et al.: Somatostatin analogues inhibit the growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc Natl Acad Sci U S A 1989; 86:2003-2007. (Pubitemid 19087056)
17. Lamberts SW, Krenning EP, Reubi JC: The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocrinol Rev 1991; 12:450-482.
18. Hofland LJ, Visser-Wisselaar HA, Lamberts SW: Somatostatin analogs: clinical application in relation to human somatostatin receptor subtypes. Biochem Pharmacol 1995; 50:287-297.
19. Chen JS, Liang QM, Li HS, et al.: Octreotide inhibits growth of colonic cancer SW480 cells by modulating the Wnt/β-catenin pathway. Pharmazie 2009; 64(2):126-131.
20. Moon RT, Bowerman B, Boutros M, et al.: The promise and perils of Wnt signaling through beta-catenin. Science 2002; 296(5573):1644-1646.
21. Doble BW, Woodgett JR: GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 2003; 116:1175-1186. (Pubitemid 36410657)
22. Hatzoglou A, Kampa M, Castanas E: Opioid-somatostatin interactions in regulating cancer cell growth. Front Biosci 2005; 10:244-256. (Pubitemid 40552762)
23. Rostomily RC, Elias M, Deng M, et al.: Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma: a case study and survey of somatostatin receptor subtype expression. Head Neck 2006; 28(4):305-312.
24. Schulte G, Bryja V: The Frizzled family of unconventional G-protein-coupled receptors. Trends Pharmacol Sci 2007; 28(10):518-525. (Pubitemid 47488504)
25. Umbhauer M, Djiane A, Goisset C, et al.: The C-terminal cytoplasmic Lys-thr-X-X-X-Trp motif in frizzled receptors mediates Wnt/beta-catenin signalling. EMBO J 2000; 19:4944-4954.
26. Kristiansen K: Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol Ther 2004; 103(1):21-80.
27. Suzuki H, Watkins DN, Jair KW, et al.: Epigenetic inactivation of SFRP genes allows constitutive Wnt signaling in colorectal cancer. Nat Genet 2004; 36(4):417-422. (Pubitemid 38437267)
28. Lee AY, He B, You L, et al.: Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma. Oncogene 2004; 23(39):6672-6676. (Pubitemid 39265531)
29. Korinek V, Barker N, Morin PJ, et al.: Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997; 275(5307):1784-1787. (Pubitemid 27136714)
30. Cadigan KM, Nusse R: Wnt signaling: a common theme in animal development. Genes Dev 1997; 11(24):3286-3305. (Pubitemid 28023954)
31. Munemitsu S, Albert I, Souza B, et al.: Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci U S A 1995; 92(7):3046-3050.
32. Park CH, Hahm ER, Lee JH, et al.: Ionomycin downregulates beta-catenin/Tcf signaling in colon cancer cell line. Carcino-genesis 2005; 26(11):1929-1933. (Pubitemid 41631266)
33. Nath N, Kashfi K, Chen J, et al.: Nitric oxide-donating aspirin inhibits beta-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear beta-catenin-TCF association. Proc Natl Acad Sci U S A 2003; 100(22):12584-12589.
34. Molenaar M, van de Wetering M, Oosterwegel M, et al.: Tcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 1996; 86(3):391-399. (Pubitemid 26272079)
35. Shtutman M, Zhurinsky J, Simcha I, et al.: The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A 1999; 96(10):5522-5527. (Pubitemid 29234650)
36. Tetsu O, McCormick F: Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398(6726):422-426. (Pubitemid 29180374)
37. He TC, Sparks AB, Rago C, et al.: Identification of c-MYC as a target of the APC pathway. Science 1998; 281(5382):1509-1512.
38. Theodoropoulou M, Zhang J, Laupheimer S, et al.: Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zac1 expression. Cancer Res 2006; 66(3):1576-1582. (Pubitemid 43259940)
39. Shi CS, Huang NN, Harrison K, et al.: The mitogen-activated protein kinase kinase kinase kinase GCKR positively regulates canonical and noncanonical Wnt signaling in B lymphocytes. Mol Cell Biol 2006; 26(17):6511-6521. (Pubitemid 44277890)